| 股票 | 标签 | 申万二级 | PE | 前瞻PE | PEG | PB | 股息率 | 分红率 | 毛利率 | 固定资产 | 债/EBITDA | FCF/市值 | 营收3年 | 去年 | YTD | 近一年 | 回撤 | 波动 | 市值亿 ▴ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 欧康医药 920230 | 中性 | 化学制药 | 79.2 | — | — | 2.65 | 1.4% | 91% | 21% | 48% | 0.5 | -1.4% | +7% | +13% | -9% | — | — | — | 11 |
| 峆一药业 920478 | 中性 | 化学制药 | 157.0 | — | — | 2.24 | 1.0% | 32% | 37% | 46% | 2.5 | -8.1% | +4% | +57% | -22% | — | — | — | 11 |
| 梓橦宫 920566 | 轻资产现金牛 | 化学制药 | 16.6 | — | — | 1.67 | 2.0% | 34% | 80% | 15% | 0.1 | 4.3% | -1% | +23% | -10% | — | — | — | 14 |
| 海昇药业 920656 | 中性 | 化学制药 | 17.9 | — | — | 2.17 | 2.6% | 38% | 52% | 28% | — | 3.6% | -6% | +41% | -9% | — | — | — | 15 |
| ST南新 688189 | 亏损或困境 | 化学制药 | — | — | — | 2.35 | — | — | 83% | 17% | — | -0.7% | -41% | +22% | -16% | -55% | -67% | 69% | 18 |
| ST天圣 002872 | 亏损或困境 | 化学制药 | — | — | — | 0.96 | — | — | 48% | 50% | 4.4 | 1.8% | -5% | +7% | +20% | +18% | -22% | 30% | 18 |
| 新赣江 920367 | 中性 | 化学制药 | 160.7 | — | — | 3.88 | 0.1% | 15% | 45% | 44% | 2.6 | -2.9% | -13% | +44% | +31% | — | — | — | 19 |
| 黄山胶囊 002817 | 中性 | 化学制药 | 33.8 | — | — | 2.07 | 1.3% | 39% | 29% | 24% | — | 5.8% | +2% | +24% | -11% | -15% | -34% | 31% | 20 |
| 星昊医药 920017 | 现金流红利 | 化学制药 | 17.7 | — | — | 1.25 | 3.6% | 54% | 74% | 40% | 0.1 | 4.5% | +2% | +33% | -6% | — | — | — | 20 |
| 西点药业 301130 | 中性 | 化学制药 | 353.7 | — | — | 2.39 | 0.5% | 50% | 80% | 51% | 1.0 | -1.0% | -3% | +10% | -4% | -17% | -34% | 50% | 21 |
| 本立科技 301065 | 重资产陷阱 | 化学制药 | 26.4 | — | — | 1.50 | 1.5% | 32% | 17% | 37% | 0.0 | -3.8% | -6% | +15% | -7% | -18% | -32% | 30% | 21 |
| 莎普爱思 603168 | 亏损或困境 | 化学制药 | — | — | — | 1.60 | — | 30% | 56% | 42% | — | -5.0% | -6% | +10% | -20% | -27% | -46% | 37% | 22 |
| 广济药业 000952 | 亏损或困境 | 化学制药 | — | — | — | 3.70 | — | — | 27% | 51% | 77.7 | 2.8% | -8% | +14% | -8% | -6% | -51% | 48% | 22 |
| 汉商集团 600774 | 亏损或困境 | 化学制药 | — | — | — | 1.49 | — | — | 62% | 49% | 5.9 | 3.5% | -9% | +22% | -16% | -25% | -49% | 39% | 22 |
| 中哲精化 000953 | 重资产陷阱 | 化学制药 | 640.9 | — | — | 14.42 | — | — | 15% | 49% | — | 0.8% | +4% | +29% | -16% | -20% | -39% | 37% | 22 |
| 仟源医药 300254 | 亏损或困境 | 化学制药 | 77.8 | — | — | 4.98 | — | — | 68% | 17% | 3.2 | 5.6% | +2% | +16% | -14% | -28% | -50% | 47% | 22 |
| 富士莱 301258 | 中性 | 化学制药 | 359.0 | — | — | 1.29 | 0.8% | 49% | 38% | 26% | 0.0 | -6.7% | -9% | +38% | -20% | -30% | -41% | 36% | 24 |
| 东亚药业 605177 | 亏损或困境 | 化学制药 | — | — | — | 1.58 | — | 30% | 27% | 59% | 27.9 | -1.0% | -7% | -10% | +23% | +5% | -40% | 43% | 25 |
| 赛托生物 300583 | 亏损或困境 | 化学制药 | 263.0 | — | — | 1.46 | 0.1% | 180% | 21% | 48% | 3.1 | 4.9% | -8% | -30% | -1% | -25% | -39% | 36% | 26 |
| 溢多利 300381 | 亏损或困境 | 化学制药 | — | — | — | 1.06 | 0.9% | 158% | 44% | 50% | 0.3 | -5.3% | -11% | -6% | -14% | -28% | -30% | 35% | 27 |
| 共同药业 300966 | 亏损或困境 | 化学制药 | — | 118.0 | 1.18 | 3.90 | 0.2% | 8% | 22% | 64% | 17.2 | -0.6% | +0% | +22% | +20% | +1% | -31% | 43% | 27 |
| 同和药业 300636 | 中性 | 化学制药 | 73.2 | 32.5 | 1.55 | 1.21 | 0.6% | 16% | 32% | 55% | 2.6 | -1.4% | +5% | -5% | -9% | -19% | -32% | 30% | 29 |
| 拓新药业 301089 | 亏损或困境 | 化学制药 | — | — | — | 1.98 | — | 13% | 38% | 51% | — | -2.3% | -22% | -1% | -18% | -35% | -42% | 41% | 29 |
| 丰原药业 000153 | 中性 | 化学制药 | 30.6 | — | — | 1.34 | 1.6% | 31% | 26% | 35% | 5.1 | 1.7% | -1% | +4% | +1% | -10% | -28% | 30% | 29 |
| 冀衡医药 002742 | 重资产陷阱 | 化学制药 | — | — | — | 19.75 | — | — | 16% | 41% | — | -3.6% | -24% | +74% | -5% | +44% | -35% | 74% | 29 |
| 康芝药业 300086 | 亏损或困境 | 化学制药 | — | — | — | 3.44 | — | — | 54% | 40% | — | 0.9% | -4% | +146% | -46% | -7% | -59% | 70% | 30 |
| 山河药辅 300452 | 中性 | 化学制药 | 16.8 | — | — | 3.00 | 2.3% | 40% | 31% | 28% | 1.3 | 5.2% | +10% | +14% | -2% | -8% | -31% | 39% | 30 |
| 海森药业 001367 | 轻资产现金牛 | 化学制药 | 22.1 | — | — | 2.01 | 0.6% | 14% | 41% | 14% | 0.0 | 4.1% | +8% | +20% | -7% | -23% | -38% | 36% | 31 |
| 海创药业 688302 | 亏损或困境 | 化学制药 | — | — | — | 3.08 | — | — | 54% | 28% | — | -5.3% | — | +60% | -36% | -50% | -50% | 50% | 31 |
| ST复华 600624 | 亏损或困境 | 化学制药 | — | — | — | 7.89 | — | — | 42% | 28% | — | -2.4% | -7% | -20% | -11% | -36% | -56% | 38% | 32 |
| 北大医药 000788 | 纯久期 | 化学制药 | 86.0 | — | — | 2.17 | 3.6% | 35% | 32% | 6% | 0.5 | 17.4% | -11% | +3% | -7% | -14% | -35% | 43% | 33 |
| 诚意药业 603811 | 中性 | 化学制药 | 18.6 | — | — | 2.33 | 3.0% | 41% | 70% | 50% | 0.3 | 6.4% | +7% | +42% | -1% | -30% | -33% | 32% | 33 |
| 华仁药业 300110 | 亏损或困境 | 化学制药 | — | — | — | 3.83 | — | 13% | 43% | 38% | 5.7 | 8.2% | -7% | -10% | -11% | -22% | -32% | 31% | 33 |
| 易明医药 002826 | 中性 | 化学制药 | 27.7 | — | — | 3.91 | 0.8% | 38% | 51% | 27% | 0.2 | 6.7% | -9% | +80% | -3% | -20% | -32% | 43% | 34 |
| 德源药业 920735 | 中性 | 化学制药 | 12.7 | — | — | 2.44 | 1.4% | 20% | 82% | 32% | 0.0 | 4.0% | +18% | +64% | -14% | — | — | — | 34 |
| 中关村 000931 | 亏损或困境 | 化学制药 | — | — | — | 2.14 | 0.4% | 31% | 58% | 26% | 3.8 | 0.5% | +6% | +2% | -7% | -19% | -32% | 37% | 34 |
| 威尔药业 603351 | 中性 | 化学制药 | 22.5 | 20.2 | 1.55 | 1.95 | 2.3% | 37% | 28% | 56% | 1.3 | 6.0% | +6% | +8% | +1% | -13% | -23% | 33% | 35 |
| 双成药业 002693 | 亏损或困境 | 化学制药 | 71.0 | — | — | 8.52 | — | — | 68% | 49% | 1.8 | 0.9% | +0% | -62% | +26% | +7% | -29% | 48% | 36 |
| 盟科药业 688373 | 亏损或困境 | 化学制药 | — | — | — | 22.35 | — | — | 83% | 0% | — | -3.2% | +43% | +22% | -8% | -28% | -57% | 52% | 36 |
| 海辰药业 300584 | 中性 | 化学制药 | 81.7 | — | — | 3.42 | 0.3% | 28% | 81% | 56% | 1.7 | -0.8% | +8% | +151% | -39% | -48% | -61% | 66% | 37 |
| 灵康药业 603669 | 亏损或困境 | 化学制药 | — | — | — | 6.40 | — | — | 47% | 35% | — | -3.0% | +4% | -13% | +14% | -17% | -39% | 47% | 37 |
| 润都股份 002923 | 中性 | 化学制药 | 276.2 | — | — | 3.45 | — | 112% | 51% | 50% | 2.1 | 4.0% | -5% | +29% | -9% | -24% | -46% | 44% | 37 |
| 司太立 603520 | 现金流红利 | 化学制药 | 183.1 | 29.6 | 0.37 | 1.55 | 3.4% | 1500% | 24% | 49% | 7.6 | -5.6% | +5% | +10% | -4% | -23% | -41% | 43% | 38 |
| 哈三联 002900 | 亏损或困境 | 化学制药 | — | — | — | 2.24 | — | 94% | 60% | 45% | — | -4.7% | -8% | +29% | -2% | -20% | -39% | 52% | 39 |
| 卫信康 603676 | 定价权·品牌 | 化学制药 | 20.5 | — | — | 2.56 | 3.6% | 60% | 53% | 20% | 0.0 | 4.0% | -7% | +10% | -12% | -27% | -37% | 28% | 40 |
| 新天地 301277 | 中性 | 化学制药 | 38.0 | — | — | 2.58 | 2.0% | 64% | 40% | 36% | 0.0 | 1.0% | +2% | +23% | -13% | -31% | -40% | 38% | 40 |
| 向日葵 300111 | 亏损或困境 | 化学制药 | — | — | — | 5.92 | — | — | 25% | 8% | 1.1 | -0.8% | -7% | +89% | -50% | -20% | -72% | 80% | 40 |
| 亚太药业 002370 | 亏损或困境 | 化学制药 | — | — | — | 3.59 | — | — | 33% | 24% | — | -1.9% | -5% | +140% | -26% | -20% | -49% | 52% | 40 |
| 立方制药 003020 | 中性 | 化学制药 | 24.8 | — | — | 2.20 | 2.4% | 58% | 52% | 37% | 0.3 | 4.0% | -16% | +50% | -17% | -44% | -51% | 46% | 40 |
| 金陵药业 000919 | 中性 | 化学制药 | 72.9 | — | — | 1.08 | 1.5% | 115% | 21% | 23% | 0.8 | 6.7% | +6% | +23% | -16% | -8% | -34% | 35% | 41 |
| 小方制药 603207 | 现金流红利 | 化学制药 | 21.2 | — | — | 3.57 | 4.2% | 90% | 65% | 27% | 0.0 | 2.0% | +5% | +11% | -11% | -27% | -39% | 32% | 41 |
| 宣泰医药 688247 | 中性 | 化学制药 | 130.7 | — | — | 3.13 | 0.4% | 32% | 56% | 24% | 0.0 | 2.5% | +22% | -3% | -6% | -25% | -38% | 40% | 41 |
| 永安药业 002365 | 中性 | 化学制药 | 79.1 | 43.5 | 3.62 | 2.11 | 0.7% | 88% | 23% | 40% | 0.0 | 0.0% | -19% | +90% | -3% | -28% | -49% | 43% | 42 |
| 力生制药 002393 | 现金流红利 | 化学制药 | 28.4 | — | — | 0.96 | 5.4% | 49% | 58% | 18% | 0.1 | 2.3% | +7% | +27% | -19% | -31% | -32% | 29% | 43 |
| 森萱医药 920946 | 中性 | 化学制药 | 28.5 | 26.3 | 1.75 | 3.40 | 1.6% | 51% | 45% | 20% | 0.1 | 4.6% | -4% | +21% | -1% | — | — | — | 44 |
| 金石亚药 300434 | 中性 | 化学制药 | 27.4 | — | — | 1.69 | 0.7% | 30% | 58% | 26% | 0.4 | 1.8% | -6% | +26% | +8% | +3% | -32% | 49% | 44 |
| 民生健康 301507 | 中性 | 化学制药 | 37.0 | 39.5 | 0.99 | 2.75 | 1.2% | 38% | 60% | 27% | 0.0 | -0.2% | +13% | +22% | -18% | -18% | -35% | 34% | 44 |
| 联环药业 600513 | 亏损或困境 | 化学制药 | — | — | — | 3.52 | 0.4% | 31% | 49% | 36% | 13.6 | -4.3% | +12% | +87% | -15% | -38% | -54% | 60% | 44 |
| 福安药业 300194 | 中性 | 化学制药 | 77.4 | — | — | 1.05 | 1.8% | 26% | 53% | 29% | 1.9 | 7.6% | -10% | +1% | -11% | -19% | -30% | 26% | 46 |
| 神奇制药 600613 | 中性 | 化学制药 | 175.8 | — | — | 2.10 | 0.8% | 100% | 50% | 34% | 0.3 | 3.2% | -6% | -10% | +50% | +30% | -36% | 44% | 48 |
| 首药控股 688197 | 亏损或困境 | 化学制药 | — | — | — | 7.79 | — | — | 99% | 2% | — | -2.4% | +68% | +16% | -7% | -38% | -41% | 55% | 48 |
| 键凯科技 688356 | 中性 | 化学制药 | 113.7 | — | — | 3.73 | 0.4% | 30% | 81% | 32% | 0.0 | 0.4% | -8% | +45% | -3% | -19% | -45% | 66% | 48 |
| 亨迪药业 301211 | 中性 | 化学制药 | 104.2 | — | — | 2.13 | 0.5% | 78% | 29% | 22% | 0.0 | -0.6% | -4% | -16% | -5% | -10% | -42% | 56% | 48 |
| 多瑞医药 301075 | 亏损或困境 | 化学制药 | — | — | — | 7.42 | — | 52% | 69% | 54% | — | -3.9% | -27% | +232% | +2% | +43% | -52% | 63% | 49 |
| 北陆药业 300016 | 中性 | 化学制药 | 34.6 | — | — | 1.97 | — | 167% | 48% | 32% | 2.5 | 1.0% | +16% | +29% | +7% | -18% | -35% | 50% | 49 |
| 金城医药 300233 | 中性 | 化学制药 | 36.1 | — | — | 1.34 | 1.9% | 77% | 44% | 40% | 0.7 | 6.0% | -8% | +21% | -5% | -32% | -43% | 36% | 50 |
| 科源制药 301281 | 中性 | 化学制药 | 131.3 | — | — | 3.54 | 0.1% | 36% | 44% | 36% | 1.8 | -1.0% | -4% | -1% | +60% | +27% | -46% | 60% | 51 |
| 吉贝尔 688566 | 中性 | 化学制药 | 24.3 | 20.8 | 0.95 | 2.05 | 2.0% | 64% | 89% | 38% | 0.0 | 2.7% | +14% | +37% | -14% | -34% | -45% | 35% | 51 |
| 罗欣药业 002793 | 亏损或困境 | 化学制药 | — | 43.4 | 0.38 | 4.61 | — | — | 46% | 19% | 15.1 | 6.0% | -14% | +26% | -1% | -18% | -35% | 44% | 52 |
| 圣诺生物 688117 | 成长兑现 | 化学制药 | 25.5 | 20.0 | 0.71 | 4.54 | 1.1% | 32% | 64% | 38% | 1.8 | 0.9% | +23% | +110% | -12% | -24% | -34% | 47% | 52 |
| 昂利康 002940 | 中性 | 化学制药 | 47.4 | — | — | 3.28 | 0.9% | 31% | 45% | 20% | 1.6 | 4.4% | -3% | +161% | -19% | -52% | -56% | 65% | 54 |
| 九典制药 300705 | 中性 | 化学制药 | 16.2 | 18.4 | 0.88 | 2.16 | 3.6% | 30% | 77% | 39% | 1.1 | 0.1% | +10% | -15% | -24% | -42% | -50% | 32% | 55 |
| 津药药业 600488 | 中性 | 化学制药 | 87.3 | — | — | 1.86 | 1.0% | 80% | 46% | 45% | 1.5 | 4.6% | -8% | -1% | +28% | +16% | -44% | 65% | 56 |
| 莱美药业 300006 | 亏损或困境 | 化学制药 | — | — | — | 3.28 | — | — | 69% | 9% | — | 0.3% | -4% | +40% | +4% | +10% | -32% | 58% | 57 |
| ST能特 002102 | 亏损或困境 | 化学制药 | — | — | — | 1.94 | — | — | 3% | 15% | 5.4 | -17.7% | -16% | +27% | -27% | -43% | -55% | 37% | 58 |
| 华特达因 000915 | 定价权·品牌 | 化学制药 | 14.1 | 10.5 | 1.17 | 2.27 | 9.8% | 110% | 84% | 19% | — | 8.4% | -2% | +31% | -18% | -21% | -30% | 24% | 59 |
| 双鹭药业 002038 | 轻资产现金牛 | 化学制药 | — | — | — | 1.23 | 0.2% | 37% | 82% | 10% | — | 8.2% | -16% | -1% | -20% | -28% | -44% | 55% | 60 |
| 悦康药业 688658 | 亏损或困境 | 化学制药 | — | — | — | 1.90 | — | 98% | 63% | 38% | 10.6 | 4.2% | -19% | +57% | -40% | -59% | -64% | 67% | 61 |
| 海南海药 000566 | 亏损或困境 | 化学制药 | — | — | — | — | — | — | 39% | 41% | — | -2.1% | -22% | +49% | -32% | -21% | -58% | 66% | 63 |
| 奥翔药业 603229 | 中性 | 化学制药 | 79.8 | — | — | 2.71 | 0.8% | 40% | 54% | 33% | 2.3 | -0.4% | +1% | +0% | -21% | -36% | -39% | 32% | 65 |
| 前沿生物 688221 | 亏损或困境 | 化学制药 | — | — | — | 6.31 | — | — | 29% | 24% | 32.8 | 0.7% | +13% | +85% | -4% | -5% | -40% | 77% | 65 |
| 辰欣药业 603367 | 中性 | 化学制药 | 14.4 | — | — | 1.03 | 2.4% | 38% | 56% | 20% | 0.1 | 7.8% | -5% | +30% | -16% | -50% | -55% | 46% | 66 |
| 尔康制药 300267 | 亏损或困境 | 化学制药 | — | — | — | 1.66 | — | — | 23% | 43% | 4.9 | -2.0% | -15% | +23% | -5% | -21% | -40% | 50% | 67 |
| 华纳药厂 688799 | 中性 | 化学制药 | 28.8 | 37.2 | 2.33 | 3.15 | 0.4% | 34% | 65% | 36% | 3.2 | -3.3% | +5% | +62% | +5% | -0% | -38% | 57% | 67 |
| 东北制药 000597 | 中性 | 化学制药 | 31.8 | — | — | 1.23 | 1.2% | 34% | 39% | 25% | 2.4 | 12.4% | -7% | +1% | -8% | -17% | -28% | 28% | 68 |
| 德展健康 000813 | 亏损或困境 | 化学制药 | — | — | — | 1.57 | — | — | 59% | 20% | — | -4.5% | -11% | +23% | -11% | -15% | -39% | 44% | 72 |
| 宏源药业 301246 | 重资产陷阱 | 化学制药 | 25.9 | 9.4 | 0.14 | 1.58 | 0.3% | 22% | 19% | 39% | 1.2 | -3.0% | -2% | +86% | -27% | +17% | -48% | 62% | 73 |
| 亚虹医药 688176 | 亏损或困境 | 化学制药 | — | — | — | 5.49 | — | — | 76% | 1% | — | -7.8% | +2098% | +70% | +13% | +3% | -48% | 59% | 74 |
| 汇宇制药 688553 | 成长兑现 | 化学制药 | 66.1 | 1198.0 | 1.06 | 2.01 | 1.1% | 95% | 86% | 28% | 3.5 | 1.8% | -13% | +21% | +1% | -35% | -46% | 56% | 75 |
| 天宇股份 300702 | 中性 | 化学制药 | 83.1 | 24.5 | 0.72 | 2.11 | 0.2% | 31% | 37% | 43% | 3.1 | 7.7% | +5% | +42% | -8% | -21% | -36% | 38% | 75 |
| 福元医药 601089 | 中性 | 化学制药 | 20.2 | — | — | 2.09 | 3.0% | 49% | 67% | 35% | 0.0 | 3.2% | +3% | +57% | -31% | -37% | -48% | 46% | 78 |
| 苑东生物 688513 | 中性 | 化学制药 | 28.3 | 26.8 | 2.44 | 2.68 | 1.1% | 32% | 80% | 32% | 0.4 | 2.3% | +4% | +109% | -27% | -37% | -48% | 60% | 79 |
| 鲁抗医药 600789 | 中性 | 化学制药 | 55.2 | — | — | 1.51 | 0.7% | 32% | 23% | 39% | 3.3 | 4.8% | +1% | -4% | -16% | -27% | -37% | 30% | 79 |
| 奥锐特 605116 | 中性 | 化学制药 | 21.4 | 16.9 | 0.89 | 3.00 | 1.7% | 31% | 56% | 44% | 1.5 | 0.3% | +19% | +21% | -20% | -17% | -47% | 42% | 80 |
| 花园生物 300401 | 中性 | 化学制药 | 29.2 | — | — | 2.42 | 0.8% | 20% | 60% | 51% | 3.4 | 1.3% | -4% | +4% | -2% | -6% | -47% | 58% | 80 |
| 华北制药 600812 | 中性 | 化学制药 | 65.2 | — | — | 1.46 | 0.7% | 187% | 32% | 31% | 7.2 | 8.4% | -4% | +8% | -15% | -28% | -36% | 27% | 80 |
| 复旦张江 688505 | 亏损或困境 | 化学制药 | — | — | — | 3.83 | — | 94% | 92% | 18% | — | 1.7% | -13% | +9% | -4% | -23% | -34% | 31% | 82 |
| 上海谊众 688091 | 纯久期 | 化学制药 | 121.8 | — | — | 5.62 | — | 30% | 93% | 18% | 0.4 | -0.3% | +10% | +18% | -14% | -44% | -51% | 59% | 84 |
| 千红制药 002550 | 中性 | 化学制药 | 28.6 | 20.5 | 0.89 | 3.07 | 2.3% | 47% | 44% | 22% | 0.1 | 2.8% | -12% | +30% | -15% | -40% | -45% | 34% | 84 |
| 仙琚制药 002332 | 现金流红利 | 化学制药 | 22.2 | 18.1 | 1.21 | 1.44 | 3.5% | 67% | 58% | 39% | 0.2 | 5.3% | -5% | -6% | -2% | -22% | -28% | 20% | 86 |
| 海翔药业 002099 | 亏损或困境 | 化学制药 | — | — | — | 1.83 | — | — | 27% | 39% | 8.4 | -1.0% | -12% | +21% | -13% | -10% | -44% | 47% | 88 |
| 誉衡药业 002437 | 中性 | 化学制药 | 21.9 | — | — | 3.56 | — | — | 58% | 29% | 0.2 | 3.2% | -12% | +23% | +28% | +9% | -38% | 52% | 88 |
| 华邦健康 002004 | 现金流红利 | 化学制药 | 13.7 | — | — | 0.87 | 10.1% | 134% | 38% | 30% | 2.9 | 18.2% | -4% | +11% | -2% | -1% | -30% | 31% | 88 |
| ST诺泰 688076 | 中性 | 化学制药 | 38.4 | — | — | 2.95 | 1.2% | 53% | 61% | 43% | 3.3 | -4.2% | +44% | +3% | -23% | -33% | -40% | 31% | 91 |
| 新华制药 000756 | 中性 | 化学制药 | 42.7 | — | — | 1.74 | 1.1% | 36% | 27% | 44% | 1.5 | 4.2% | +5% | -0% | -14% | -20% | -34% | 37% | 92 |
| 美诺华 603538 | 中性 | 化学制药 | 79.5 | 62.1 | 2.07 | 3.17 | 0.4% | 32% | 35% | 38% | 2.3 | 0.6% | +1% | +53% | +100% | +41% | -53% | 71% | 93 |
| 富祥股份 300497 | 重资产陷阱 | 化学制药 | 76.4 | 15.2 | 0.69 | 4.17 | 0.3% | — | 17% | 48% | 4.2 | -0.4% | -10% | +82% | +21% | +68% | -34% | 66% | 98 |
| 泰恩康 301263 | 中性 | 化学制药 | — | 67.6 | 0.41 | 6.07 | 0.2% | 77% | 57% | 23% | 14.8 | -0.4% | -5% | +96% | -19% | -34% | -44% | 46% | 100 |
| 海欣股份 600851 | 中性 | 化学制药 | 51.9 | — | — | 2.04 | 0.6% | 34% | 47% | 8% | 1.7 | -0.9% | -19% | +19% | +25% | +16% | -26% | 45% | 103 |
| 必贝特 688759 | 亏损或困境 | 化学制药 | — | — | — | 6.54 | — | — | 42% | 4% | — | -1.5% | — | — | -20% | — | -62% | 77% | 104 |
| 东诚药业 002675 | 中性 | 化学制药 | 52.3 | 39.5 | 1.52 | 2.39 | 0.6% | 36% | 45% | 27% | 2.1 | -0.0% | -8% | +13% | -7% | -27% | -30% | 30% | 105 |
| 奥赛康 002755 | 亏损或困境 | 化学制药 | 55.1 | 28.2 | 0.76 | 3.37 | 1.0% | 59% | 81% | 9% | 0.0 | 1.2% | -2% | +30% | -28% | -54% | -54% | 46% | 109 |
| 京新药业 002020 | 中性 | 化学制药 | 15.1 | 13.4 | 0.84 | 1.82 | 2.6% | 42% | 51% | 27% | 0.2 | 6.0% | +2% | +54% | -32% | -35% | -45% | 43% | 109 |
| 赛分科技 688758 | 中性 | 化学制药 | 59.9 | 60.3 | 1.63 | 7.92 | 0.4% | 24% | 71% | 14% | 0.6 | 1.0% | +24% | — | +50% | +28% | -29% | 52% | 110 |
| 石药景峰 000908 | 亏损或困境 | 化学制药 | — | — | — | 5.26 | — | — | 63% | 13% | 1.6 | -1.1% | -23% | +47% | +74% | +118% | -37% | 68% | 110 |
| 微芯生物 688321 | 中性 | 化学制药 | 120.3 | 79.9 | 1.13 | 4.60 | 0.2% | 46% | 89% | 32% | 6.6 | -1.5% | +20% | +57% | -14% | -34% | -38% | 46% | 112 |
| 益方生物 688382 | 亏损或困境 | 化学制药 | — | — | — | 8.01 | — | — | 92% | 0% | — | -2.2% | — | +105% | -28% | -54% | -63% | 69% | 113 |
| 舒泰神 300204 | 亏损或困境 | 化学制药 | — | — | — | 14.04 | — | — | 81% | 15% | — | -1.7% | -26% | +269% | -23% | -66% | -66% | 70% | 113 |
| 国药现代 600420 | 中性 | 化学制药 | 20.9 | 13.5 | 1.35 | 0.83 | 3.5% | 37% | 38% | 26% | 0.0 | 7.4% | -10% | -14% | -14% | -24% | -31% | 23% | 114 |
| 亿帆医药 002019 | 中性 | 化学制药 | 38.7 | 25.9 | 1.08 | 1.33 | 1.0% | 46% | 47% | 21% | 3.1 | 0.7% | +10% | +13% | -19% | -40% | -42% | 34% | 117 |
| 国邦医药 605507 | 中性 | 化学制药 | 17.3 | 11.1 | 0.53 | 1.45 | 2.8% | 55% | 26% | 38% | 0.8 | 3.8% | +2% | +23% | -10% | -4% | -28% | 31% | 122 |
| 浙江医药 600216 | 中性 | 化学制药 | 15.1 | 11.0 | 1.10 | 1.05 | 2.2% | 31% | 35% | 38% | 0.5 | 8.4% | +3% | -11% | -7% | -21% | -39% | 34% | 122 |
| 迈威生物 688062 | 亏损或困境 | 化学制药 | — | — | — | 14.02 | — | — | 90% | 34% | — | -7.3% | +188% | +90% | -29% | -33% | -57% | 62% | 122 |
| 健友股份 603707 | 轻资产现金牛 | 化学制药 | 26.4 | 18.6 | 0.81 | 1.84 | 1.3% | 24% | 48% | 10% | 2.9 | 9.1% | +2% | -32% | -12% | -32% | -41% | 29% | 127 |
| 兴齐眼药 300573 | 成长兑现 | 化学制药 | 16.9 | 11.4 | 0.36 | 6.17 | 3.1% | 77% | 78% | 51% | 0.1 | 4.5% | +26% | +46% | -21% | -17% | -38% | 40% | 133 |
| 海正药业 600267 | 中性 | 化学制药 | 15.6 | — | — | 1.53 | 1.8% | 43% | 43% | 50% | 0.8 | 8.5% | -2% | +23% | +20% | +4% | -20% | 37% | 137 |
| 纳微科技 688690 | 中性 | 化学制药 | 68.0 | 59.1 | 1.56 | 6.85 | 0.3% | 30% | 78% | 25% | 0.1 | 1.2% | +9% | +48% | +37% | +22% | -30% | 57% | 143 |
| 海普瑞 002399 | 纯久期 | 化学制药 | 71.1 | — | — | 1.21 | 1.5% | 59% | 33% | 13% | 3.2 | 9.7% | -8% | +13% | -16% | -26% | -35% | 31% | 144 |
| 广生堂 300436 | 亏损或困境 | 化学制药 | — | — | — | 72.02 | — | — | 62% | 38% | — | -0.8% | +3% | +173% | +1% | -41% | -42% | 75% | 151 |
| 博瑞医药 688166 | 中性 | 化学制药 | 157.5 | 158.1 | 0.41 | 4.97 | 0.0% | 20% | 56% | 42% | 7.9 | -0.1% | +6% | +63% | -29% | -68% | -73% | 69% | 152 |
| 通化金马 000766 | 中性 | 化学制药 | 647.4 | — | — | 6.87 | — | — | 75% | 20% | 11.9 | 0.2% | -7% | +75% | -40% | -33% | -49% | 45% | 159 |
| 一品红 300723 | 亏损或困境 | 化学制药 | 72.9 | — | — | 8.71 | — | 50% | 81% | 38% | — | 0.4% | -26% | +97% | +6% | -49% | -60% | 65% | 161 |
| 华润双鹤 600062 | 中性 | 化学制药 | 10.3 | 9.3 | 1.16 | 1.36 | 3.0% | 30% | 56% | 25% | 0.5 | 4.9% | +5% | -6% | -11% | -19% | -22% | 20% | 166 |
| 健康元 600380 | 中性 | 化学制药 | 14.0 | 11.8 | 1.97 | 1.10 | 2.4% | 27% | 63% | 18% | 1.2 | 20.2% | -4% | +4% | -19% | -28% | -32% | 26% | 168 |
| 川宁生物 301301 | 中性 | 化学制药 | 31.7 | 20.8 | 1.30 | 2.35 | 2.1% | 51% | 29% | 49% | 1.0 | 4.4% | +6% | -13% | -16% | -33% | -35% | 31% | 187 |
| 哈药股份 600664 | 中性 | 化学制药 | 38.3 | 32.4 | 1.91 | 3.21 | — | — | 26% | 15% | 1.3 | 1.8% | +5% | -16% | +126% | +98% | -34% | 51% | 196 |
| 翰宇药业 300199 | 亏损或困境 | 化学制药 | 157.7 | — | — | 23.71 | — | — | 58% | 52% | 5.1 | 0.1% | +11% | +39% | +28% | -21% | -41% | 55% | 202 |
| 贝达药业 300558 | 成长兑现 | 化学制药 | 44.3 | 36.1 | 1.09 | 3.13 | 0.3% | 20% | 84% | 28% | 2.0 | 1.3% | +15% | -13% | +5% | -33% | -46% | 56% | 207 |
| 常山药业 300255 | 亏损或困境 | 化学制药 | — | — | — | 17.95 | — | — | 22% | 40% | — | -1.1% | -28% | +211% | -63% | -56% | -69% | 69% | 213 |
| 恩华药业 002262 | 中性 | 化学制药 | 20.8 | 19.3 | 1.38 | 2.72 | 1.8% | 32% | 74% | 16% | 0.0 | 1.8% | +11% | +1% | -5% | -8% | -36% | 30% | 229 |
| 丽珠集团 000513 | 现金流红利 | 化学制药 | 14.2 | 11.5 | 0.96 | 1.78 | 5.3% | 63% | 65% | 19% | 1.2 | 11.9% | -2% | -7% | -19% | -33% | -37% | 24% | 238 |
| 华海药业 600521 | 中性 | 化学制药 | 38.1 | 27.0 | — | 2.51 | 0.6% | 35% | 60% | 44% | 4.2 | 0.2% | +1% | -4% | -5% | -29% | -48% | 40% | 239 |
| 普洛药业 000739 | 中性 | 化学制药 | 30.5 | 24.7 | 1.23 | 3.94 | 2.6% | 40% | 26% | 28% | 0.9 | 1.7% | -2% | +5% | +39% | +39% | -20% | 40% | 259 |
| 迪哲医药 688192 | 亏损或困境 | 化学制药 | — | 12.4 | — | 23.49 | — | — | 96% | 12% | — | -2.6% | — | +39% | -1% | -31% | -55% | 60% | 265 |
| ST人福 600079 | 中性 | 化学制药 | 15.1 | — | — | 1.58 | 2.6% | 42% | 45% | 24% | 1.6 | 6.7% | +2% | -22% | +6% | -8% | -30% | 25% | 306 |
| 泽璟制药 688266 | 亏损或困境 | 化学制药 | 56.8 | 58.7 | — | 18.15 | — | — | 92% | 14% | 1.4 | 2.1% | +39% | +49% | +27% | +6% | -37% | 63% | 312 |
| 信立泰 002294 | 中性 | 化学制药 | 52.0 | 44.4 | 1.85 | 4.09 | 1.8% | 95% | 73% | 14% | 0.7 | 0.2% | +8% | +64% | -36% | -40% | -56% | 55% | 350 |
| 华东医药 000963 | 现金流红利 | 化学制药 | 13.9 | 12.8 | 1.60 | 1.89 | 3.4% | 46% | 32% | 13% | 0.4 | 5.8% | +5% | +18% | -30% | -40% | -41% | 32% | 480 |
| 艾力斯 688578 | 定价权·品牌 | 化学制药 | 18.6 | 17.4 | 1.16 | 5.88 | 1.1% | 21% | 96% | 5% | 0.0 | 5.1% | +87% | +78% | +7% | +20% | -32% | 48% | 497 |
| 诺诚健华 688428 | 亏损或困境 | 化学制药 | 61.0 | 179.2 | — | 7.31 | — | — | 86% | 6% | 2.5 | 0.3% | +56% | +67% | +54% | +7% | -35% | 53% | 561 |
| 复星医药 600196 | 中性 | 化学制药 | 17.6 | 15.5 | 0.82 | 1.22 | 1.7% | 31% | 48% | 17% | 6.0 | 1.2% | -2% | +8% | -14% | -22% | -34% | 28% | 597 |
| 石药创新 300765 | 中性 | 化学制药 | 60.3 | — | — | 15.66 | — | 50% | 43% | 33% | 0.5 | 3.4% | -6% | +36% | +22% | -19% | -60% | 69% | 616 |
| 科伦药业 002422 | 中性 | 化学制药 | 36.5 | — | — | 2.71 | 1.4% | 47% | 52% | 30% | 1.4 | 3.4% | -1% | +0% | +45% | +9% | -29% | 47% | 667 |
| 海思科 002653 | 纯久期 | 化学制药 | 83.2 | 78.3 | — | 16.39 | 1.1% | 116% | 71% | 10% | 1.6 | 1.2% | +13% | +57% | +37% | +18% | -31% | 52% | 789 |
| 百利天恒 688506 | 亏损或困境 | 化学制药 | — | — | — | 23.42 | — | — | 75% | 8% | — | -1.5% | +53% | +68% | -19% | -21% | -50% | 56% | 1080 |
| 恒瑞医药 600276 | 中性 | 化学制药 | 39.5 | 32.9 | 1.94 | 4.74 | 0.4% | 20% | 86% | 12% | 0.0 | 1.8% | +14% | +30% | -22% | -30% | -37% | 34% | 3054 |
| 百济神州 688235 | 亏损或困境 | 化学制药 | 93.0 | — | — | 11.24 | — | — | 85% | 17% | 1.0 | 3.9% | +59% | +67% | +1% | +6% | -36% | 49% | 3982 |
点表头排序。市值单位亿元;去年/YTD 为前复权涨幅;债/EBITDA = 有息负债 ÷ EBITDA。